Czechia, Oct. 28 -- Czechia based PHOENIX lekarensky velkoobchod, s.r.o. has secured contract from Institut klinicke a experimentalni mediciny for Immunosuppressive agents - Immunosuppressive agents TNF alpha inhibitors Infliximab sc administration II (hereinafter also only "order" or "VZ"). The value of the contract is worth 71083745.2 CZK.

Published by HT Digital Content Services with permission from Pivotal Sources....